Brief: Simcere Pharmaceutical Sees Profit Attributable RMB427 Mln To RMB487 Mln For Six Months
30/07/2024 16:40
July 30 (Reuters) - Simcere Pharmaceutical Group Ltd
2096.HK :
* SEES PROFIT ATTRIBUTABLE RMB427 MILLION TO RMB487 MILLION
FOR
SIX MONTHS
* SEES REVENUE OF RMB3,084 MILLION TO RMB3,144 MILLION FOR
SIX
MONTHS
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660